Effects of donepezil on memory and cognition in multiple sclerosis

Journal of the Neurological Sciences
Christopher ChristodoulouLauren B Krupp

Abstract

Acetylcholinesterase inhibitors are used to treat dementia associated with Alzheimer's disease, but their cognitive benefits may extend to additional disorders such as multiple sclerosis (MS). A single-center double-blind placebo-controlled randomized clinical trial evaluated the effectiveness of donepezil in a sample of 69 MS persons selected for initial memory difficulties. Subjects received neuropsychological assessment at baseline and after 24 weeks of treatment. The primary outcome was change in total recall on the Selective Reminding Test, a measure of verbal learning and memory. Secondary outcomes included other neuropsychological tests from the Brief Repeatable Battery, patient-reported change in memory, and physician-reported impression of cognitive change. Donepezil improved memory performance on the SRT compared to placebo. This benefit remained significant after controlling for various covariates including Expanded Disability Status Scale (EDSS), MS subtype, interferon beta use, treatment group beliefs, gender, baseline selected reminding test (SRT) score, and reading ability. Subjects on donepezil were more likely to report memory improvement (65.7%) than those on placebo (32.4%). The clinician also reported cognit...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Jun 1, 1988·Journal of Personality and Social Psychology·D WatsonA Tellegen
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Sep 1, 1980·Archives of Neurology·J M PeyserS B Filskov
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·M L FureyU Freo
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
May 12, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·A M PlohmannJ Lechner-Scott
Dec 9, 1998·Journal of Clinical and Experimental Neuropsychology·J DeLucaR A Engel
Apr 13, 1999·Lancet·P S KishnaniK R Krishnan
Jul 17, 1999·The Journal of Head Trauma Rehabilitation·J A Whitlock
Feb 24, 2001·Science·T W RobbinsB J Sahakian
Aug 15, 2001·Neurology·B WinbladUNKNOWN Donepezil Nordic Study Group
Sep 11, 2001·Multiple Sclerosis : Clinical and Laboratory Research·J B BoringaC H Polman
Jan 23, 2002·European Neurology·Yoram Barak, Anat Achiron
May 23, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·D AarslandC Janvin
Mar 4, 2003·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Jeffrey L Cummings
Mar 6, 2003·Clinical Rehabilitation·Nancy D ChiaravallotiJohn DeLuca
Jun 5, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Martin S MumenthalerHelena C Kraemer
Aug 27, 2003·Neurology·D WilkinsonUNKNOWN Donepezil 308 Study Group

❮ Previous
Next ❯

Citations

May 16, 2007·Journal of Neurology·Alexander WinkelmannUwe K Zettl
Jan 13, 2012·Journal of Neurology·Nancy D ChiaravallotiJohn Deluca
Jul 10, 2012·Journal of Neurology·Serafin BeerJürg Kesselring
Dec 19, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·T AntonelliE Granieri
Aug 2, 2011·Current Neurology and Neuroscience Reports·Vijayshree Yadav, Dennis N Bourdette
Jun 14, 2008·Chemico-biological Interactions·David A Jett
Mar 2, 2012·Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence·William S MacAllisterLana Harder
Jan 16, 2007·Annual Review of Medicine·Philip L De Jager, David A Hafler
Jun 23, 2011·Therapeutic Advances in Neurological Disorders·Teresa C FrohmanElliot M Frohman
Dec 15, 2010·Drug Design, Development and Therapy·Laurie J BartenMichael P Rivey
Jul 8, 2014·Journal of the International Neuropsychological Society : JINS·Dede M Ukueberuwa, Peter A Arnett
Mar 18, 2010·International Review of Psychiatry·Lambros MessinisPanagiotis Papathanasopoulos
Apr 23, 2011·Expert Opinion on Investigational Drugs·Niels PlathJohn Paul Redrobe
Mar 29, 2011·Neurologic Clinics·Lawrence M Samkoff, Andrew D Goodman
Mar 29, 2011·Neurologic Clinics·Laura J Julian
Oct 22, 2008·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Cinthia M MazzantiMaria Rosa C Schetinger
Jul 31, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Jeffrey M Rogers, Peter K Panegyres
Aug 7, 2007·Critical Reviews in Oncology/hematology·Janette Vardy, Ian Tannock
May 1, 2007·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Cinthia M MazzantiMaria Rosa C Schetinger
Feb 4, 2010·Chemico-biological Interactions·Sultan DarveshJohn D Fisk
Jan 3, 2014·Clinical & Developmental Immunology·Nathalie DeckxNathalie Cools
May 3, 2007·Expert Opinion on Pharmacotherapy·Ben Seltzer
May 3, 2011·Consciousness and Cognition·Daniel Collerton, Elaine Perry
Aug 24, 2010·Arquivos de neuro-psiquiatria·Maria Lúcia Brito Ferreira
May 21, 2010·Multiple Sclerosis : Clinical and Laboratory Research·J F LoveraD Bourdette
Sep 23, 2008·Multiple Sclerosis : Clinical and Laboratory Research·F Patti
Sep 8, 2010·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Ian M Devonshire, Eleanor J Dommett
Dec 18, 2013·The Cochrane Database of Systematic Reviews·Dian HeHongyu Zhou
Jun 8, 2013·The Cochrane Database of Systematic Reviews·Graziella FilippiniGeorgia Salanti
Sep 19, 2012·Nature Reviews. Neurology·Valentina TomassiniJacqueline Palace
Nov 1, 2008·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Vahid ShaygannejadNaser Zakizade
Apr 17, 2020·Drug Delivery and Translational Research·Atinderpal KaurShweta Dang
Aug 4, 2020·International Journal of Preventive Medicine·Mohammad Mahdi ShahpouriVahid Shaygannejad
Jan 20, 2012·The Cochrane Database of Systematic Reviews·Loredana La MantiaGraziella Filippini
Feb 18, 2016·CNS Drugs·Shumita RoyBianca Weinstock-Guttman
Feb 20, 2020·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Fugen GuChunzhi Wu
Jan 15, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Huaqing ZhangYang Ding
Nov 15, 2008·Lancet Neurology·Nancy D Chiaravalloti, John DeLuca

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.